Dr. Anna Nolan, MD

Media Releases

Combining Clinical Expertise with Innovative Research to Tackle Lung Disease and Improve Patient Outcomes

New York, New York – Anna Nolan, MD, a skilled pulmonologist and physician-scientist, proudly serves as the Director of Research Oversight at NYC Health + Hospitals / Bellevue, while also treating adults at NYU Langone Pulmonary And Critical Care Associates on 41st Street. With her extensive background in pulmonary and critical care medicine, Dr. Nolan is dedicated to advancing the field through both clinical practice and groundbreaking research.

As a Professor in the Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine at NYU Grossman School of Medicine, Dr. Nolan brings a wealth of knowledge and experience to her role. She earned her Bachelor of Arts Degree in Chemistry from Barnard College in 1992 and her Medical Degree from SUNY-Downstate’s College of Medicine in 1996. Following her internal medicine residency at St. Luke’s-Roosevelt Hospital Center, she completed a fellowship in pulmonary and critical care medicine at NYU Grossman School of Medicine in 2003 and obtained her Master of Science Degree in Clinical Investigation from the same institution in 2007.

Dr. Nolan is board-certified in internal medicine, pulmonary disease, and critical care medicine, with certifications dating back to 1999, 2002, and 2003, respectively. She is a Fellow of both the American College of Chest Physicians and the American Thoracic Society, as well as a member of the Society of Critical Care Medicine.

Currently, as Principal Investigator of the Nolan Lab at NYU Langone, Dr. Nolan leads a team focused on investigating the impact of World Trade Center dust exposure on lung function using mouse models. Her research also delves into the roles of the receptor for advanced glycation end products (RAGE) and lysophosphatidic acid (LPA), a cholesterol derivative, as part of her broader interests that include COVID-19, biomarkers, and lung inflammation. 

Dr. Nolan’s innovative approach incorporates machine learning and artificial intelligence to develop prediction models aimed at understanding metabolic syndrome, cardiovascular disease, and aerodigestive conditions. Her work is crucial in examining the impact of these conditions on lung health and overall disease progression.

Fluent in English and Greek, Dr. Nolan is committed to improving health outcomes for diverse communities in New York City. Her dedication to research and patient care continues to inspire fellow clinicians and researchers alike.

Recommended Articles

• The History of Muscular Dystrophy

  What is muscular dystrophy?Muscular dystrophy is an inherited disorder, which is often characterized by a progressive type of muscular degeneration and weakness. There are several types of muscular dystrophy, wherein each type eventually leads to an increased disability, strength loss, and potential...

• 32-year-old with Cystic Fibrosis Raises Millions for Research

  32-year old Emily Kramer-Golinkoff has accomplished more in her life than most people can say. Though she was diagnosed with a life-long debilitating disease as an infant, she has refused to let the fate she was dealt with drag her down. This young woman is the founder of a non-profit called Emily's...

• What Is Pleurisy: Get the Facts

  What is pleurisy?The pleural membrane is a very thin membrane that surrounds your lungs. It has two layers:...

• Cystic Fibrosis: The Importance of Bone Health

  Anyone living with cystic fibrosis knows that the lungs, GI tract, pancreas, and other organs are damaged by the caustic mucus it produces.However, some might be unaware that the absorption of food nutrients, including calcium, is severely hampered by the disease’s damage to the small intestines....

• Groundbreaking Triple-Therapy Could Be on the Horizon for Cystic Fibrosis

  Researchers work around the clock and the world to find new discoveries in terms of cystic fibrosis treatment. Thanks to foundations, donations, and ongoing research, cystic fibrosis has made leaps and bounds as far as treatment is concerned. There is one pharmaceutical company at the forefront of...

• Helping a Child with Cystic Fibrosis Find Hope

  Cystic fibrosis is a serious and debilitating illness that is lifelong, affecting people often from infancy. What some people may not realize is how difficult it may be for children to understand what is happening to their body.Most small children with the disease have gone through more difficult...